Cargando…

Homogeneous polyporus polysaccharide inhibits bladder cancer by polarizing macrophages to M1 subtype in tumor microenvironment

BACKGROUND: Polyporus polysaccharide (PPS), an active ingredient of traditional Chinese medicinal Polyporus umbellatus, has multiple biological functions, such as anti-cancer, immune-regulating and hepatoprotective activities. The purpose of this study was to investigate the mechanism of homogeneous...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Wenyu, Luo, Siwan, Lai, Gena, Li, Shiqi, Huo, Shuai, Li, Meifang, Zeng, Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152148/
https://www.ncbi.nlm.nih.gov/pubmed/34034714
http://dx.doi.org/10.1186/s12906-021-03318-x
_version_ 1783698544559915008
author Jia, Wenyu
Luo, Siwan
Lai, Gena
Li, Shiqi
Huo, Shuai
Li, Meifang
Zeng, Xing
author_facet Jia, Wenyu
Luo, Siwan
Lai, Gena
Li, Shiqi
Huo, Shuai
Li, Meifang
Zeng, Xing
author_sort Jia, Wenyu
collection PubMed
description BACKGROUND: Polyporus polysaccharide (PPS), an active ingredient of traditional Chinese medicinal Polyporus umbellatus, has multiple biological functions, such as anti-cancer, immune-regulating and hepatoprotective activities. The purpose of this study was to investigate the mechanism of homogeneous polyporus polysaccharide (HPP) activated macrophages in the treatment of bladder cancer. METHODS: 100 ng/mL Phorbol myristate acetate (PMA) was used to induce THP-1 human leukemic cells as a macrophage model. Then macrophages derived from THP-1 were treated with different concentrations of HPP (1, 10 and 100 μg/mL). Flow cytometry and RT-PCR were used to detected the expression of CD16, CD23, CD86, CD40 and interleukin (IL)-Iβ, iNOS mRNA. ELISA was used to test the change of IL-1β and TNF-α in macrophage after the treatment with HPP. The conditioned medium from HPP-polarized macrophages was used to detect the effect of activated macrophages on bladder cancer. MTT assay, 5-ethynyl-2′-deoxyuridine assay, flow cytometry, Transwell assay, and Western blot analysis were used to detect the effects of polarized macrophages on the viability, proliferation, apoptosis, and migration of bladder cancer cells. Western blot was also used to analysis the change of JAK2/NF-κB pathway protein. RESULTS: HPP promoted the expression of pro-inflammatory factors, such as IL-Iβ, TNF-α and iNOS, and surface molecules CD86, CD16, CD23, and CD40 in macrophages and then polarized macrophages to M1 type. Results demonstrated that activated macrophages inhibited the proliferation of bladder cancer cells, regulated their apoptosis, and inhibited migration and epithelial–mesenchymal transformation (EMT). JAK2/NF-κB pathways were downregulated in the anti-bladder cancer process of activated macrophages. CONCLUSION: The findings indicated that HPP inhibited the proliferation and progression of bladder cancer by the polarization of macrophages to M1 type, and JAK2/NF-κB pathway was downregulated in the process of anti-bladder cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12906-021-03318-x.
format Online
Article
Text
id pubmed-8152148
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81521482021-05-26 Homogeneous polyporus polysaccharide inhibits bladder cancer by polarizing macrophages to M1 subtype in tumor microenvironment Jia, Wenyu Luo, Siwan Lai, Gena Li, Shiqi Huo, Shuai Li, Meifang Zeng, Xing BMC Complement Med Ther Research BACKGROUND: Polyporus polysaccharide (PPS), an active ingredient of traditional Chinese medicinal Polyporus umbellatus, has multiple biological functions, such as anti-cancer, immune-regulating and hepatoprotective activities. The purpose of this study was to investigate the mechanism of homogeneous polyporus polysaccharide (HPP) activated macrophages in the treatment of bladder cancer. METHODS: 100 ng/mL Phorbol myristate acetate (PMA) was used to induce THP-1 human leukemic cells as a macrophage model. Then macrophages derived from THP-1 were treated with different concentrations of HPP (1, 10 and 100 μg/mL). Flow cytometry and RT-PCR were used to detected the expression of CD16, CD23, CD86, CD40 and interleukin (IL)-Iβ, iNOS mRNA. ELISA was used to test the change of IL-1β and TNF-α in macrophage after the treatment with HPP. The conditioned medium from HPP-polarized macrophages was used to detect the effect of activated macrophages on bladder cancer. MTT assay, 5-ethynyl-2′-deoxyuridine assay, flow cytometry, Transwell assay, and Western blot analysis were used to detect the effects of polarized macrophages on the viability, proliferation, apoptosis, and migration of bladder cancer cells. Western blot was also used to analysis the change of JAK2/NF-κB pathway protein. RESULTS: HPP promoted the expression of pro-inflammatory factors, such as IL-Iβ, TNF-α and iNOS, and surface molecules CD86, CD16, CD23, and CD40 in macrophages and then polarized macrophages to M1 type. Results demonstrated that activated macrophages inhibited the proliferation of bladder cancer cells, regulated their apoptosis, and inhibited migration and epithelial–mesenchymal transformation (EMT). JAK2/NF-κB pathways were downregulated in the anti-bladder cancer process of activated macrophages. CONCLUSION: The findings indicated that HPP inhibited the proliferation and progression of bladder cancer by the polarization of macrophages to M1 type, and JAK2/NF-κB pathway was downregulated in the process of anti-bladder cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12906-021-03318-x. BioMed Central 2021-05-25 /pmc/articles/PMC8152148/ /pubmed/34034714 http://dx.doi.org/10.1186/s12906-021-03318-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jia, Wenyu
Luo, Siwan
Lai, Gena
Li, Shiqi
Huo, Shuai
Li, Meifang
Zeng, Xing
Homogeneous polyporus polysaccharide inhibits bladder cancer by polarizing macrophages to M1 subtype in tumor microenvironment
title Homogeneous polyporus polysaccharide inhibits bladder cancer by polarizing macrophages to M1 subtype in tumor microenvironment
title_full Homogeneous polyporus polysaccharide inhibits bladder cancer by polarizing macrophages to M1 subtype in tumor microenvironment
title_fullStr Homogeneous polyporus polysaccharide inhibits bladder cancer by polarizing macrophages to M1 subtype in tumor microenvironment
title_full_unstemmed Homogeneous polyporus polysaccharide inhibits bladder cancer by polarizing macrophages to M1 subtype in tumor microenvironment
title_short Homogeneous polyporus polysaccharide inhibits bladder cancer by polarizing macrophages to M1 subtype in tumor microenvironment
title_sort homogeneous polyporus polysaccharide inhibits bladder cancer by polarizing macrophages to m1 subtype in tumor microenvironment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152148/
https://www.ncbi.nlm.nih.gov/pubmed/34034714
http://dx.doi.org/10.1186/s12906-021-03318-x
work_keys_str_mv AT jiawenyu homogeneouspolyporuspolysaccharideinhibitsbladdercancerbypolarizingmacrophagestom1subtypeintumormicroenvironment
AT luosiwan homogeneouspolyporuspolysaccharideinhibitsbladdercancerbypolarizingmacrophagestom1subtypeintumormicroenvironment
AT laigena homogeneouspolyporuspolysaccharideinhibitsbladdercancerbypolarizingmacrophagestom1subtypeintumormicroenvironment
AT lishiqi homogeneouspolyporuspolysaccharideinhibitsbladdercancerbypolarizingmacrophagestom1subtypeintumormicroenvironment
AT huoshuai homogeneouspolyporuspolysaccharideinhibitsbladdercancerbypolarizingmacrophagestom1subtypeintumormicroenvironment
AT limeifang homogeneouspolyporuspolysaccharideinhibitsbladdercancerbypolarizingmacrophagestom1subtypeintumormicroenvironment
AT zengxing homogeneouspolyporuspolysaccharideinhibitsbladdercancerbypolarizingmacrophagestom1subtypeintumormicroenvironment